Annual CFF
$1.02 M
-$599.85 K-36.98%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual cash flow from financing activities is $1.02 million, with the most recent change of -$599.85 thousand (-36.98%) on December 31, 2023.
- During the last 3 years, CHRO annual CFF has fallen by -$2.60 million (-71.80%).
- CHRO annual CFF is now -71.80% below its all-time high of $3.63 million, reached on December 1, 2020.
Performance
CHRO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$972.28 K
-$2.56 M-161.25%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly cash flow from financing activities is -$972.28 thousand, with the most recent change of -$2.56 million (-161.25%) on September 30, 2024.
- Over the past year, CHRO quarterly CFF has dropped by -$1.40 million (-325.90%).
- CHRO quarterly CFF is now -117.16% below its all-time high of $5.67 million, reached on March 31, 2024.
Performance
CHRO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.71 M
-$1.17 M-14.85%
September 30, 2024
Summary
- As of February 7, 2025, CHRO TTM cash flow from financing activities is $6.71 million, with the most recent change of -$1.17 million (-14.85%) on September 30, 2024.
- Over the past year, CHRO TTM CFF has increased by +$5.69 million (+556.47%).
- CHRO TTM CFF is now -14.85% below its all-time high of $7.88 million, reached on June 30, 2024.
Performance
CHRO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CHRO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.0% | -325.9% | +556.5% |
| 3 y3 years | -71.8% | -326.9% | +525.0% |
| 5 y5 years | -71.8% | -326.9% | +525.0% |
CHRO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.0% | at low | -117.2% | at low | -14.8% | +1810.4% |
| 5 y | 5-year | -71.8% | at low | -117.2% | at low | -14.8% | +1810.4% |
| alltime | all time | -71.8% | at low | -117.2% | at low | -14.8% | +1810.4% |
Chromocell Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$972.28 K(-161.3%) | $6.71 M(-14.8%) |
| Jun 2024 | - | $1.59 M(-72.0%) | $7.88 M(+20.9%) |
| Mar 2024 | - | $5.67 M(+1216.4%) | $6.52 M(+537.9%) |
| Dec 2023 | $1.02 M | $430.41 K(+117.3%) | $1.02 M(-10.4%) |
| Sep 2023 | - | $198.10 K(-12.7%) | $1.14 M(-16.8%) |
| Jun 2023 | - | $226.90 K(+35.9%) | $1.37 M(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $166.90 K(-69.6%) | $1.44 M(-11.4%) |
| Dec 2022 | $1.62 M(+1.8%) | $548.50 K(+28.0%) | $1.62 M(+51.1%) |
| Sep 2022 | - | $428.60 K(+45.9%) | $1.07 M(+66.4%) |
| Jun 2022 | - | $293.80 K(-16.4%) | $645.10 K(+83.6%) |
| Mar 2022 | - | $351.30 K | $351.30 K |
| Dec 2021 | $1.59 M(-56.1%) | - | - |
| Dec 2020 | $3.63 M | - | - |
FAQ
- What is Chromocell Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual CFF year-on-year change?
- What is Chromocell Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly CFF year-on-year change?
- What is Chromocell Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Chromocell Therapeutics?
- What is Chromocell Therapeutics TTM CFF year-on-year change?
What is Chromocell Therapeutics annual cash flow from financing activities?
The current annual CFF of CHRO is $1.02 M
What is the all time high annual CFF for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual cash flow from financing activities is $3.63 M
What is Chromocell Therapeutics annual CFF year-on-year change?
Over the past year, CHRO annual cash flow from financing activities has changed by -$599.85 K (-36.98%)
What is Chromocell Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CHRO is -$972.28 K
What is the all time high quarterly CFF for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly cash flow from financing activities is $5.67 M
What is Chromocell Therapeutics quarterly CFF year-on-year change?
Over the past year, CHRO quarterly cash flow from financing activities has changed by -$1.40 M (-325.90%)
What is Chromocell Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CHRO is $6.71 M
What is the all time high TTM CFF for Chromocell Therapeutics?
Chromocell Therapeutics all-time high TTM cash flow from financing activities is $7.88 M
What is Chromocell Therapeutics TTM CFF year-on-year change?
Over the past year, CHRO TTM cash flow from financing activities has changed by +$5.69 M (+556.47%)